BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 24401008)

  • 21. Relationship between daily and visit-to-visit glycemic variability in patients with type 2 diabetes.
    Tsuchiya T; Saisho Y; Murakami R; Watanabe Y; Inaishi J; Itoh H
    Endocr J; 2020 Aug; 67(8):877-881. PubMed ID: 32389920
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Albuminuria, glycemic variability and effect of flash glucose monitoring based decision making on short term glycemic variability in Indian type 2 diabetes patients: Indi-GlyVar study.
    Nathiya D; Singh M; Suman S; Bareth H; Pal N; Jain A; Tomar BS
    Front Endocrinol (Lausanne); 2022; 13():1011411. PubMed ID: 36465630
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Glycemic Variability and Vascular Complications in Patients with Type 2 Diabetes Mellitus.
    Caprnda M; Mesarosova D; Ortega PF; Krahulec B; Egom E; Rodrigo L; Kruzliak P; Mozos I; Gaspar L
    Folia Med (Plovdiv); 2017 Sep; 59(3):270-278. PubMed ID: 28976897
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of real-time continuous glucose monitoring in type 1 diabetes: a meta-analysis of randomized controlled trials.
    Dicembrini I; Cosentino C; Monami M; Mannucci E; Pala L
    Acta Diabetol; 2021 Apr; 58(4):401-410. PubMed ID: 32789691
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metabolic syndrome associated with higher glycemic variability in type 1 diabetes: A multicenter cross-sectional study in china.
    Guo K; Zhang L; Ye J; Niu X; Jiang H; Gan S; Zhou J; Yang L; Zhou Z
    Front Endocrinol (Lausanne); 2022; 13():972785. PubMed ID: 36204109
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hypoglycemia, but not glucose variability, relates to vascular function in children with type 1 diabetes.
    Peña AS; Couper JJ; Harrington J; Gent R; Fairchild J; Tham E; Baghurst P
    Diabetes Technol Ther; 2012 Jun; 14(6):457-62. PubMed ID: 22313018
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Glycemic variability in insulin treated type 2 diabetes with well-controlled hemoglobin A1c and its response to further treatment with acarbose.
    Su JB; Wang XQ; Chen JF; Wu G; Jin Y
    Chin Med J (Engl); 2011 Jan; 124(1):144-7. PubMed ID: 21362322
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Glycemic Variability and Diabetic Neuropathy in Young Adults With Type 1 Diabetes.
    Christensen MMB; Hommel EE; Jørgensen ME; Fleischer J; Hansen CS
    Front Endocrinol (Lausanne); 2020; 11():644. PubMed ID: 33071962
    [No Abstract]   [Full Text] [Related]  

  • 29. Do data in the literature indicate that glycaemic variability is a clinical problem? Glycaemic variability and vascular complications of diabetes.
    Cavalot F
    Diabetes Obes Metab; 2013 Sep; 15 Suppl 2():3-8. PubMed ID: 24034513
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Glucose Variability Assessed with Continuous Glucose Monitoring: Reliability, Reference Values, and Correlations with Established Glycemic Indices-The Maastricht Study.
    Foreman YD; Brouwers MCGJ; van der Kallen CJH; Pagen DME; van Greevenbroek MMJ; Henry RMA; Koster A; Wesselius A; Schaper NC; Stehouwer CDA
    Diabetes Technol Ther; 2020 May; 22(5):395-403. PubMed ID: 31886732
    [No Abstract]   [Full Text] [Related]  

  • 31. Association of glycemic variability and hypoglycemia with distal symmetrical polyneuropathy in adults with type 1 diabetes.
    Shen Z; Jiang H; Huang R; Zhou Y; Li Q; Ma J
    Sci Rep; 2021 Nov; 11(1):22875. PubMed ID: 34819569
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of glycemic variability on the HbA1c level in elderly male patients with type 2 diabetes.
    Fang FS; Li ZB; Li CL; Tian H; Li J; Cheng XL
    Intern Med; 2012; 51(22):3109-13. PubMed ID: 23154714
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Poincaré plot quantification for assessing glucose variability from continuous glucose monitoring systems and a new risk marker for hypoglycemia: application to type 1 diabetes patients switching to continuous subcutaneous insulin infusion.
    Crenier L
    Diabetes Technol Ther; 2014 Apr; 16(4):247-54. PubMed ID: 24237387
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative predictive ability of visit-to-visit HbA1c variability measures for microvascular disease risk in type 2 diabetes.
    Yang CY; Su PF; Hung JY; Ou HT; Kuo S
    Cardiovasc Diabetol; 2020 Jul; 19(1):105. PubMed ID: 32631323
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of Glycemic Variability in Type 1 Diabetes With Progression of Microvascular Outcomes in the Diabetes Control and Complications Trial.
    Lachin JM; Bebu I; Bergenstal RM; Pop-Busui R; Service FJ; Zinman B; Nathan DM;
    Diabetes Care; 2017 Jun; 40(6):777-783. PubMed ID: 28404658
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Associations between continuous glucose monitoring-derived metrics and arterial stiffness in Japanese patients with type 2 diabetes.
    Wakasugi S; Mita T; Katakami N; Okada Y; Yoshii H; Osonoi T; Kuribayashi N; Taneda Y; Kojima Y; Gosho M; Shimomura I; Watada H
    Cardiovasc Diabetol; 2021 Jan; 20(1):15. PubMed ID: 33413339
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of Factory-Calibrated Real-time Continuous Glucose Monitoring Improves Time in Target and HbA
    Thabit H; Prabhu JN; Mubita W; Fullwood C; Azmi S; Urwin A; Doughty I; Leelarathna L
    Diabetes Care; 2020 Oct; 43(10):2537-2543. PubMed ID: 32723843
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Glucose variability indices in type 1 diabetes: parsimonious set of indices revealed by sparse principal component analysis.
    Fabris C; Facchinetti A; Sparacino G; Zanon M; Guerra S; Maran A; Cobelli C
    Diabetes Technol Ther; 2014 Oct; 16(10):644-52. PubMed ID: 24956070
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of real-time continuous glucose monitoring in pregnant women with diabetes: a randomized controlled trial.
    Secher AL; Ringholm L; Andersen HU; Damm P; Mathiesen ER
    Diabetes Care; 2013 Jul; 36(7):1877-83. PubMed ID: 23349548
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Effect of Canagliflozin, a Sodium Glucose Cotransporter 2 Inhibitor, on Glycemic End Points Assessed by Continuous Glucose Monitoring and Patient-Reported Outcomes Among People With Type 1 Diabetes.
    Rodbard HW; Peters AL; Slee A; Cao A; Traina SB; Alba M
    Diabetes Care; 2017 Feb; 40(2):171-180. PubMed ID: 27899497
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.